- Home
- Publications
- Publication Search
- Publication Details
Title
Perspective on the dynamics of cancer
Authors
Keywords
Cancer dynamics, Tumor microenvironment, Cardinal signaling pathways, Cancer inflammation, Tumor immunosuppression, Dysregulated cellular processes, Cancer associated fibroblasts, Tumor associated macrophages
Journal
Theoretical Biology and Medical Modelling
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-09-06
DOI
10.1186/s12976-017-0066-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells
- (2017) Marcella Manerba et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- TGF-β Family Signaling in Tumor Suppression and Cancer Progression
- (2017) Joan Seoane et al. Cold Spring Harbor Perspectives in Biology
- Targeting MYC Dependence by Metabolic Inhibitors in Cancer
- (2017) Himalee S. Sabnis et al. Genes
- Stromal Modulators of TGF-β in Cancer
- (2017) Brunella Costanza et al. Journal of Clinical Medicine
- Silencing Nrf2 impairs glioma cell proliferation via AMPK-activated mTOR inhibition
- (2016) Yue Jia et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dichotomous roles of TGF-β in human cancer
- (2016) Jennifer J. Huang et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Tumor microenvironment and cancer therapy resistance
- (2016) Yu Sun CANCER LETTERS
- Targeting Inflammation in Cancer Prevention and Therapy
- (2016) J. Todoric et al. Cancer Prevention Research
- AMPK Activation and Metabolic Reprogramming by Tamoxifen through Estrogen Receptor-Independent Mechanisms Suggests New Uses for This Therapeutic Modality in Cancer Treatment
- (2016) N. A. Daurio et al. CANCER RESEARCH
- Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy
- (2016) Zhiyu Wang et al. CURRENT DRUG TARGETS
- TGF-β Signaling in Cancer
- (2016) Viqar Syed JOURNAL OF CELLULAR BIOCHEMISTRY
- Alisertib induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells
- (2016) YUNFENG FU et al. Molecular Medicine Reports
- Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition
- (2016) Aaron Boudreau et al. Nature Chemical Biology
- Cancer metabolism: a therapeutic perspective
- (2016) Ubaldo E. Martinez-Outschoorn et al. Nature Reviews Clinical Oncology
- Therapy for colorectal cancer liver metastases: understanding resistance
- (2016) Katrina Ray Nature Reviews Gastroenterology & Hepatology
- Role of the tumor microenvironment in tumor progression and the clinical applications (Review)
- (2016) YAO YUAN et al. ONCOLOGY REPORTS
- Therapeutics targeting innate immune/inflammatory responses through the interleukin-6/JAK/STAT signal transduction pathway in patients with cancer
- (2016) Campbell S.D. Roxburgh et al. Translational Research
- A systems study reveals concurrent activation of AMPK and mTOR by amino acids
- (2016) Piero Dalle Pezze et al. Nature Communications
- Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival
- (2016) Edoardo Gaude et al. Nature Communications
- Feedback, Mass Conservation and Reaction Kinetics Impact the Robustness of Cellular Oscillations
- (2016) Katharina Baum et al. PLoS Computational Biology
- Metabolic control of signalling pathways and metabolic auto-regulation
- (2015) Doriane Lorendeau et al. BIOLOGY OF THE CELL
- Lactate promotes glutamine uptake and metabolism in oxidative cancer cells
- (2015) Jhudit Pérez-Escuredo et al. CELL CYCLE
- Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA
- (2015) A. T. Ooi et al. CLINICAL CANCER RESEARCH
- The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles to effective cancer therapy
- (2015) Zutao Yu et al. Future Medicinal Chemistry
- A Novel Dual AMPK Activator/mTOR Inhibitor Inhibits Thyroid Cancer Cell Growth
- (2015) Robert L. Plews et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Recent Update on Human Lactate Dehydrogenase Enzyme 5 (hLDH5) Inhibitors: A Promising Approach for Cancer Chemotherapy
- (2015) Reshma Rani et al. JOURNAL OF MEDICINAL CHEMISTRY
- The future of breast cancer systemic therapy: the next 10 years
- (2015) Melinda L. Telli et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Targeted therapy for gastric cancer: Current status and future directions (Review)
- (2015) DAN-DAN YUAN et al. ONCOLOGY REPORTS
- Targeting the TGFβ pathway for cancer therapy
- (2015) Cindy Neuzillet et al. PHARMACOLOGY & THERAPEUTICS
- Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types
- (2015) Paolo Gandellini et al. SEMINARS IN CANCER BIOLOGY
- Cancer-Associated Fibroblasts Connect Metastasis-Promoting Communication in Colorectal Cancer
- (2015) Joke Tommelein et al. Frontiers in Oncology
- Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer
- (2015) Nikita Pozdeyev et al. PLoS One
- Targeting epigenetic regulators for cancer therapy
- (2014) Susan Wee et al. Annals of the New York Academy of Sciences
- Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin
- (2014) Katherine A. Hoadley et al. CELL
- The Future of Cancer Therapy: Selecting Patients Likely to Respond to PD1/L1 Blockade
- (2014) A. Ribas et al. CLINICAL CANCER RESEARCH
- Sweat but no gain: Inhibiting proliferation of multidrug resistant cancer cells with “ersatzdroges”
- (2014) Yoonseok Kam et al. INTERNATIONAL JOURNAL OF CANCER
- Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
- (2014) Xiaozhou Fan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Discovery and saturation analysis of cancer genes across 21 tumour types
- (2014) Michael S. Lawrence et al. NATURE
- Targeting RAS–ERK signalling in cancer: promises and challenges
- (2014) Ahmed A. Samatar et al. NATURE REVIEWS DRUG DISCOVERY
- Regulation of the anti-tumour immune response by cancer-associated fibroblasts
- (2014) James Harper et al. SEMINARS IN CANCER BIOLOGY
- Navigating the Challenge of Tumor Heterogeneity in Cancer Therapy
- (2014) C. Fedele et al. Cancer Discovery
- Cytotoxic T Lymphocyte Antigen-4 Blockade Enhances Antitumor Immunity by Stimulating Melanoma-Specific T-cell Motility
- (2014) T. Pentcheva-Hoang et al. Cancer Immunology Research
- Lactate, a Novel Trigger of Transforming Growth Factor-β Activation in Idiopathic Pulmonary Fibrosis
- (2013) Rubin M. Tuder et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
- (2013) Jedd D. Wolchok et al. Annals of the New York Academy of Sciences
- Chronic inflammation and cancer: suppressing the suppressors
- (2013) Michal Baniyash et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
- (2013) J. R. Doherty et al. CANCER RESEARCH
- Forkhead box P3 regulatory T cells coexisting with cancer associated fibroblasts are correlated with a poor outcome in lung adenocarcinoma
- (2013) Tomonari Kinoshita et al. CANCER SCIENCE
- Clinical significance of macrophage heterogeneity in human malignant tumors
- (2013) Yoshihiro Komohara et al. CANCER SCIENCE
- Lactate dehydrogenase a in cancer: A promising target for diagnosis and therapy
- (2013) Ping Miao et al. IUBMB LIFE
- Targeting lactate metabolism for cancer therapeutics
- (2013) Joanne R. Doherty et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy
- (2013) Maria Themeli et al. NATURE BIOTECHNOLOGY
- Heterogeneity of tumor-induced gene expression changes in the human metabolic network
- (2013) Jie Hu et al. NATURE BIOTECHNOLOGY
- Pan-cancer patterns of somatic copy number alteration
- (2013) Travis I Zack et al. NATURE GENETICS
- Emerging landscape of oncogenic signatures across human cancers
- (2013) Giovanni Ciriello et al. NATURE GENETICS
- Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
- (2013) Paul F Robbins et al. NATURE MEDICINE
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of LDH-A by oxamate induces G2/M arrest, apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells
- (2013) XIAOMING ZHAI et al. ONCOLOGY REPORTS
- Targeting the NF-κB Pathway in Cancer Therapy
- (2013) Derek J. Erstad et al. Surgical Oncology Clinics of North America
- Comprehensive identification of mutational cancer driver genes across 12 tumor types
- (2013) David Tamborero et al. Scientific Reports
- Resistance to PARP-Inhibitors in Cancer Therapy
- (2013) Alicia Montoni et al. Frontiers in Pharmacology
- Natural and Induced T Regulatory Cells in Cancer
- (2013) Dennis O. Adeegbe et al. Frontiers in Immunology
- Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells
- (2012) Ying-Hui Ko et al. CANCER BIOLOGY & THERAPY
- Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
- (2012) Hsing-Chen Tsai et al. CANCER CELL
- Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
- (2012) M. A. Swartz et al. CANCER RESEARCH
- Reciprocal Metabolic Reprogramming through Lactate Shuttle Coordinately Influences Tumor-Stroma Interplay
- (2012) T. Fiaschi et al. CANCER RESEARCH
- Molecular Pathways: Targeting the TGF- Pathway for Cancer Therapy
- (2012) A. L. Smith et al. CLINICAL CANCER RESEARCH
- Challenges in targeting cancer metabolism for cancer therapy
- (2012) Ryuji Yamaguchi et al. EMBO REPORTS
- Targeting the EGFR signaling pathway in cancer therapy
- (2012) Parthasarathy Seshacharyulu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeting the PI3K signaling pathway in cancer therapy
- (2012) Chandra Bartholomeusz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeting the PI3K pathway for cancer therapy
- (2012) Navid Sadeghi et al. Future Medicinal Chemistry
- ON MODELING OF LIVING ORGANISMS USING HIERARCHICAL COARSE-GRAINING ABSTRACTIONS OF KNOWLEDGE
- (2012) YOUCEF DERBAL JOURNAL OF BIOLOGICAL SYSTEMS
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Negative feedback confers mutational robustness in yeast transcription factor regulation
- (2012) C. M. Denby et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation
- (2012) Laura Tornatore et al. TRENDS IN CELL BIOLOGY
- Cancer Therapy Targeting the HER2-PI3K Pathway: Potential Impact on the Heart
- (2012) Giannoula L. Klement et al. Frontiers in Pharmacology
- Autoimmunity associated with immunotherapy of cancer
- (2011) S. M. Amos et al. BLOOD
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect
- (2011) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- Targeted Therapy in Colorectal Cancer: Current Status and Future Challenges
- (2011) A.K. Koutras et al. CURRENT MEDICINAL CHEMISTRY
- Targeting the RB-pathway in Cancer Therapy
- (2010) E. S. Knudsen et al. CLINICAL CANCER RESEARCH
- Impairment of Aerobic Glycolysis by Inhibitors of Lactic Dehydrogenase Hinders the Growth of Human Hepatocellular Carcinoma Cell Lines
- (2010) Luigi Fiume et al. PHARMACOLOGY
- Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
- (2010) A. Le et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- Blockade of a Chemokine, CCL2, Reduces Chronic Colitis-Associated Carcinogenesis in Mice
- (2009) B. K. Popivanova et al. CANCER RESEARCH
- CCL2 and Interleukin-6 Promote Survival of Human CD11b+Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization
- (2009) Hernan Roca et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Nuclear Factor NF- B Pathway in Inflammation
- (2009) T. Lawrence Cold Spring Harbor Perspectives in Biology
- Non-Smad pathways in TGF-β signaling
- (2008) Ying E Zhang CELL RESEARCH
- The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages
- (2008) Paola Allavena et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cancer complexity slows quest for cure
- (2008) Erika Check Hayden NATURE
- Life, logic and information
- (2008) Paul Nurse NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started